ArticleFrontiers in nutrition2025
The association between nutritional assessment tools and CT-assessed sarcopenia in abdominal aortic aneurysm: a cross-sectional study.
Article in Frontiers in nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- A LASSO-based nomogram for predicting sarcopenia-related nutritional risk in esophageal cancer patients: model development, validation, and an interactive clinical decision tool.Frontiers in oncology · 2026Article
- Hierarchical Evaluation of Predictive Models for Confirmed Sarcopenia: Discrimination, Calibration, and Clinical Applicability in a Cross-Sectional Study of Older Adults.Journal of clinical medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To evaluate the correlation between computed tomography (CT)-assessed sarcopenia and nutritional assessment tools in patients with abdominal aortic aneurysm (AAA). Methods: In this single-center retrospective study, 232 AAA patients admitted to our hospital between January 2022 and December 2024 were included. Patients' demographic characteristic were collected. Nutritional assessment tools were calculated, including the nutritional risk screening 2002 (NRS2002), controlling nutritional status (CONUT) score, geriatric nutritional risk index (GNRI), and prognostic nutritional index (PNI). Sarcopenia was diagnosed through CT measured skeletal muscle mass index at the third lumbar vertebra level, including rectus abdominis, internal/external obliques, transversus abdominis, erector spinae, quadratus lumborum, and psoas muscles. Logistic regression analysis was used to assess the association between nutritional assessment tools and sarcopenia in AAA patients. The optimal cutoff values of each nutritional assessment tools for screening sarcopenia in AAA patients were determined based on receiver operating characteristic (ROC) curve analysis. Results: Multivariate regression analysis revealed that NRS2002 (odds ratio [OR] 1.83, 95% confidence interval [CI] 1.27 ~ 2.63), CONUT (OR 1.40, 95% CI 1.18 ~ 1.66), and GNRI (OR 0.90, 95% CI 0.85 ~ 0.95) were independently associated with sarcopenia in AAA patients ( Conclusion: NRS2002 and GNRI demonstrated potential as supportive assessment methods. Their clinical utility as independent screening tools in sarcopenia among AAA patients remained limited due to their respective low sensitivity/specificity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.